Skip to main content

Want a detailed portfolio tracker?

Lite Strategy (LITS) P/E (2011 - 2026)

Lite Strategy (LITS) P/E from Jun 30, 2011 to Jul 21, 2026. The TTM Lite Strategy (LITS) P/E is -0.57. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Lite Strategy (LITS)

YearP/EChange
2026-0.57-29.70%
2025-0.81-37.78%
2024-1.30-57.59%
2023-3.06+19.05%
2022-2.57-90.88%
2021-28.21+1.14%
2020-27.89+6.45%
2019-26.20-6.06%
2018-27.89-89.18%
2017-257.67+1664.63%
2016-14.60+8.28%
2015-13.49-24.87%
2014-17.95-64.48%
2013-50.54+189.68%
2012-17.45-30.92%
2011-25.26N/A

Comparison Lite Strategy (LITS) P/E with competitors

Lite Strategy (LITS) P/E is -0.57.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.30%
NBYStablecoin Development Corp0.00-100.76%
ENLVEnlivex Ltd0.07-113.16%
FGENFibroGen Inc0.24-142.23%
CHRSCoherus Biosciences Inc0.85-249.29%
FBIOFortress Biotech Inc0.95-266.98%
ORMPOramed Pharmaceuticals Inc1.50-364.45%
AGENAgenus Inc3.01-629.52%
INVAInnoviva Inc3.15-654.93%
VXRTVaxart Inc3.55-724.56%
CRMDCorMedix Inc3.63-738.40%
CVACCureVac N.V.4.45-882.19%
GLPGGalapagos NV4.86-954.89%
SRPTSarepta Therapeutics Inc4.88-958.97%
ABEOAbeona Therapeutics Inc5.39-1047.90%
ABUSArbutus Biopharma Corp5.60-1084.52%
ZVRAZevra Therapeutics Inc5.89-1135.82%
SPROSpero Therapeutics Inc6.23-1195.86%
CGENCompugen Ltd6.31-1210.90%
RIGLRigel Pharmaceuticals6.87-1309.10%
SLXNSilexion Therapeutics Corp7.30-1383.70%
OMEROmeros Corporation9.26-1729.02%
AUPHAurinia Pharmaceuticals Inc9.58-1786.42%
PLXProtalix BioTherapeutics Inc10.89-2016.21%
ACADAcadia Pharmaceuticals Inc11.73-2163.57%
TBPHTheravance Biopharma Inc12.26-2257.46%
ADMAAdma Biologics Inc12.42-2284.91%
HRMYHarmony Biosciences Holdings Inc13.82-2531.59%
SABSSAB Biotherapeutics Inc14.14-2587.19%
NAGENiagen Bioscience Inc14.82-2707.17%
INCYIncyte Corp15.82-2883.89%
REGNRegeneron Pharmaceuticals Inc15.86-2889.89%
PBYIPuma Biotechnology Inc17.32-3146.61%
CPRXCatalyst Pharmaceuticals Inc17.44-3168.35%
EXELExelixis Inc17.54-3185.72%
TGTXTG Therapeutics Inc18.97-3436.98%
MDXGMimedx Group Inc20.55-3716.11%
XOMAXOMA Royalty Corp22.87-4124.79%
ARGXArgen X SE24.30-4375.22%
CTMXCytomX Therapeutics Inc24.82-4467.26%
XOMAOXOMA Royalty Corp25.34-4559.40%
HALOHalozyme Therapeutics Inc25.62-4608.48%
XOMAPXOMA Royalty Corp25.67-4616.64%
VRTXVertex Pharmaceuticals Inc27.99-5025.66%
RPRXRoyalty Pharma plc - Class A28.69-5147.56%
SLNOSoleno Therapeutics Inc29.02-5205.23%
ASNDAscendis Pharma A/S30.09-5393.53%
LGNDLigand Pharmaceuticals Inc - Class B37.91-6770.60%
APLSApellis Pharmaceuticals Inc39.02-6965.76%
BMRNBiomarin Pharmaceutical Inc42.21-7527.15%
KRYSKrystal Biotech Inc45.34-8078.16%
ONCBeiGene Ltd69.54-12335.61%
PHARPharming Group N.V.75.03-13300.71%
TECHBio-Techne Corp101.96-18039.53%
VCELVericel Corp109.92-19440.61%
ALNYAlnylam Pharmaceuticals Inc117.96-20855.90%
GMABGenmab140.29-24784.09%
TLXTelix Pharmaceuticals Ltd162.15-28630.71%
CORTCorcept Therapeutics Inc212.86-37552.18%